Citations

Citations to this article as recorded by  

• Genetic Landscape and Its Prognostic Impact in Children With Langerhans Cell Histiocytosis
  Chan-Juan Wang, Lei Cui, Shuang-Shuang Li, Hong-Hao Ma, Dong Wang, Hong-Yun Lian, Yun-Ze Zhao, Li-Ping Zhang, Wei-Jing Li, Qing Zhang, Xiao-Xi Zhao, Ying Yang, Xiao-Tong Huang, Wei Liu, Yi-Zhuo Wang, Wan-Shui Wu, Tian-You Wang, Rui Zhang, Zhi-Gang Li
  Archives of Pathology & Laboratory Medicine.2025; 149(2): 175.     CrossRef
• Targeted therapy and immunotherapy for orbital and periorbital tumors: a major review
  Emmanuel Lee Boniao, Richard C. Allen, Gangadhara Sundar
  Orbit.2024; 43(5): 656.     CrossRef
• Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone
  Wenqian Wang, Jian Ge, Honghao Ma, Hongyun Lian, Lei Cui, Yunze Zhao, Zhigang Li, Tianyou Wang, Rui Zhang
  BMC Pediatrics.2024;[Epub]     CrossRef
• Vemurafenib combined with chemotherapy achieved sustained remission in pediatric LCH: a multi-center observational study
  Jiaying Lei, Wenxia Wang, Danna Lin, Chengguang Zhu, Wenguang Jia, Wenjun Weng, Xiaoshan Liu, Yuhan Ma, Zhixuan Wang, Lihua Yang, Xiangling He, Yunyan He, Yang LI
  Journal of Cancer Research and Clinical Oncology.2024;[Epub]     CrossRef
• Clinical features and treatment outcomes of liver involvement in paediatric Langerhans cell histiocytosis
  Xinshun Ge, Wenxin Ou, Ang Wei, Hongyun Lian, Honghao Ma, Lei Cui, Dong Wang, Liping Zhang, Xiaoman Wang, Lejian He, Rui Zhang, Tianyou Wang
  BMC Pediatrics.2024;[Epub]     CrossRef
• Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib
  Isaac Hauk, Ignacio Gonzalez‐Gomes, Deepak Chellapandian, Jonathan Metts, Peter H. Shaw
  Pediatric Blood & Cancer.2024;[Epub]     CrossRef
• Advancements in the understanding and management of histiocytic neoplasms
  Kyung-Nam Koh, Su Hyun Yoon, Sung Han Kang, Hyery Kim, Ho Joon Im
  Blood Research.2024;[Epub]     CrossRef
• Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium
  Paul G. Kemps, F. J. Sherida H. Woei-A-Jin, Patrick Schöffski, Thomas Tousseyn, Isabelle Vanden Bempt, Friederike A. G. Meyer-Wentrup, Natasja Dors, Natasha K. A. van Eijkelenburg, Marijn A. Scheijde-Vermeulen, Ingrid M. Jazet, Maarten Limper, Margot Jak,
  Blood Neoplasia.2024; 1(3): 100023.     CrossRef
• The clinical impact of serum soluble CD25 levels in children with Langerhans cell histiocytosis
  Zi-Jing Zhao, Hong-Yun Lian, Wei-Jing Li, Qing Zhang, Hong-Hao Ma, Dong Wang, Yun-Ze Zhao, Ting Zhu, Hua-Lin Li, Xiao-Tong Huang, Tian-You Wang, Rui Zhang, Lei Cui, Zhi-Gang Li
  Jornal de Pediatria.2024;[Epub]     CrossRef
• Liver transplantation in a child with sclerosing cholangitis due to Langerhans cell histiocytosis: a case report
  Xue-Lian Wang, Chun-Xiao Fang, Min-Xia Chen, Hua-Mei Yang, Lan-Hui She, Yu Gong, Yi Xu, Wei-Qiang Xiao, Jin-Sheng Tian, Bin Ai, Li Huang, Xu-Fang Li
  Frontiers in Pediatrics.2024;[Epub]     CrossRef
• BRAF V600E gene mutation is present in primary intraosseous Rosai-Dorfman disease
  Lokman Cevik, Swati Satturwar, Dan Jones, Joel Mayerson, Steve Oghumu, O. Hans Iwenofu
  Human Pathology.2024; 154: 105702.     CrossRef
• Langerhans cell histiocytosis as a clonal disease of mononuclear phagocyte system
  Evgeniy F. Khynku, Maria K. Monaenkova, Olga B. Tamrazova, Alexey V. Taganov, Мarina А. Gureeva, Gayane E. Bagramova, Anton V. Molochkov
  Almanac of Clinical Medicine.2023; 50(7): 428.     CrossRef
• Lineage switching of the cellular distribution of BRAF V600E in multisystem Langerhans cell histiocytosis
  Paul Milne, Simon Bomken, Olga Slater, Ashish Kumar, Adam Nelson, Somak Roy, Jessica Velazquez, Kshitij Mankad, James Nicholson, Dan Yeomanson, Richard Grundy, Ahmed Kamal, Anthony Penn, Jane Pears, Gerard Millen, Bruce Morland, James Hayden, Jason Lam, M
  Blood Advances.2023; 7(10): 2171.     CrossRef
• Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors
  Ashley V. Geerlinks, Oussama Abla
  Pediatric Drugs.2023; 25(4): 399.     CrossRef
• Dabrafenib, alone or in combination with trametinib, in BRAF V600–mutated pediatric Langerhans cell histiocytosis
  James A. Whitlock, Birgit Geoerger, Ira J. Dunkel, Michael Roughton, Jeea Choi, Lisa Osterloh, Mark Russo, Darren Hargrave
  Blood Advances.2023; 7(15): 3806.     CrossRef
• Therapiestrategien bei Kindern und Jugendlichen mit Langerhanszell Histiozytosen
  Anke Elisabeth Barnbrock, Caroline Hutter, Konrad Bochennek, Milen Minkov, Thomas Lehrnbecher
  Klinische Pädiatrie.2023; 235(06): 342.     CrossRef
• Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms
  Benjamin H. Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, Mariko Yabe, Young Rock Chung, Gilad Itchaki, Maayan Ben-Sasson, Vered A. Asher-Guz, David Groshar, Seyram A. Doe-Tetteh, Tina Alano, David B. Solit, Ofer Shpilberg, Eli L. Diamond, Roei D. M
  Blood Advances.2023; 7(23): 7319.     CrossRef
• Validation of Liquid Chromatography Coupled with Tandem Mass Spectrometry for the Determination of 12 Tyrosine Kinase Inhibitors (TKIs) and Their Application to Therapeutic Drug Monitoring in Adult and Pediatric Populations
  Marie Bellouard, Jean Donadieu, Pauline Thiebot, Etienne Giroux Leprieur, Philippe Saiag, Isabelle Etting, Pamela Dugues, Emuri Abe, Jean-Claude Alvarez, Islam-Amine Larabi
  Pharmaceutics.2023; 16(1): 5.     CrossRef
• Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease
  Oussama Abla
  Hematology.2023; 2023(1): 386.     CrossRef
• Characteristics and Treatment Outcomes of Pediatric Langerhans Cell Histiocytosis with Thymic Involvement
  Ja-Feng Yao, Dong Wang, Hong-Hao Ma, Hong-Yun Lian, Li Zhang, Tian-You Wang, Zhi-Gang Li, Jin Jiang, Lei Cui, Rui Zhang
  The Journal of Pediatrics.2022; 244: 194.     CrossRef
• Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis
  Dong Wang, Xi-Hua Chen, Ang Wei, Chun-Ju Zhou, Xue Zhang, Hong-Hao Ma, Hong-Yun Lian, Li Zhang, Qing Zhang, Xiao-Tong Huang, Chan-Juan Wang, Ying Yang, Wei Liu, Tian-You Wang, Zhi-Gang Li, Lei Cui, Rui Zhang
  Orphanet Journal of Rare Diseases.2022;[Epub]     CrossRef
• Current perspectives on the role of liver transplantation for Langerhans cell histiocytosis: A narrative review
  Jagadeesh Menon, Ashwin Rammohan, Mukul Vij, Naresh Shanmugam, Mohamed Rela
  World Journal of Gastroenterology.2022; 28(30): 4044.     CrossRef
• Research Progress of BRAF V600E Gene Mutation in Papillary Thyroid Carcinoma
  延泽 刘
  Advances in Clinical Medicine.2022; 12(09): 8499.     CrossRef
• Recent advances in the understanding of the molecular pathogenesis and targeted therapy options in Langerhans cell histiocytosis
  Jin Kyung Suh, Sunghan Kang, Hyery Kim, Ho Joon Im, Kyung-Nam Koh
  BLOOD RESEARCH.2021; 56(S1): S65.     CrossRef

• Improvement in Pituitary Imaging After Targeted Therapy in Three Children with BRAF-Mutated Langerhans Cell Histiocytosis with Pituitary Involvement

  
  Ying Yang, Dong Wang, Na Li, Honghao Ma, Hongyun Lian, Lei Cui, Qing Zhang, Xiaoxi Zhao, Liping Zhang, Yunze Zhao, Chanjuan Wang, Li Zhang, Tianyou Wang, Zhigang Li, Rui Zhang
  OncoTargets and Therapy.2020; Volume 13: 12357.     CrossRef